Clinical Trial Update: A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC) [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating the combination of vedolizumab and tofacitinib in adults with Ulcerative Colitis is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• Entyvio (vedolizumab)
• XELJANZ (tofacitinib)

Snippet

Sponsor: Takeda | Conditions: Ulcerative Colitis | Phase 4 | Status: RECRUITING